Rich country aid amounts to a bad sandwich in Boston
BARCELONA – Most countries African countries had no or very little patent laws denying them access to cheaper drugs, according to Amir Attaran of the Kennedy School at Harvard University.
Attaran, who received a mixed reaction from his audience at the International AIDS Conference (he was booed by some activists), said that South Africa was an exception with extensive patent coverage, but that more than 50 of the 53 countries reviewed had less than 4 out of the 15 essential anti-retrovirals patented.
‘This brings one to the conclusion that patents are not the real hurdle to access,’ he said.
He said this was shown in Namibia where there were no patent laws, but where access to anti-retrovirals was almost non-existent.
‘The sad reality is that only a few countries are treating despite the fact that regimens strongly recommended are almost unpatented.’
He said that in some African countries, such as Kenya, the patented drugs were cheaper than the generic versions.
Attaran said the preferred solution was to voluntarily outlicense patents in poor countries (especially in South Africa where patents are a barrier). ‘This option is a million times better than a carpet bombing strategy of compulsory licenses. It will not work,’ he said.
Attaran pointed out that in India none of the anti-retroviral compounds were under patent, that there were several generic companies competing and that all the generics were locally manufactured (nullifying foreign exchange constraints), but that only 20 000 Indians were on treatment.
Turning to the issue of foreign aids, Attaran said that the developed world was giving the equivalent of $5 per HIV infected person. ‘That’s the price of a bad sandwich in Boston,’ he quipped.
Top of the list is the United Kingdom with aid amounting to U$147-million, compared to U$3-million from Germany. But said Attaran, ‘that (UK money) is half the production cost of the movie Titanic’.
‘Nothing much is being done and it’s a crime.’
Attaran said that official development assistance from the US to low income countries had been steadily cut to U$1 per person over the past few years.
‘The lack of aid funding must be addressed. It is not useful to go into unnecessary arguments about patents, we need to get the money to save lives.
‘Should we seek reconciliation with the private sector they can help us. They can be important allies in attacking rich countries to get the money they deserve.’
Questioned on the situation in South Africa, Attaran said that in South Africa there were many barriers to accessing treatment and that despite the court case victory against the pharmaceutical companies, Government had no intention to treat.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Rich country aid amounts to a bad sandwich in Boston
by Anso Thom, Health-e News
July 11, 2002